Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader, Wickersham & Taft LLP, a leading counselor to global financial institutions and corporations, announced today that client Élan Corporation, plc, a biotechnology company headquartered in Ireland, will purchase from Theravance, Inc. a 21% participation interest in potential future royalty payments related to four respiratory programs partnered with GlaxoSmithKline plc. https://www.cadwalader.com/news/news-release/cadwalader-advises-elan-corporation-in-billion-dollar-royalty-deal